Li Xu

机构：Zhejiang Lab, Viva Biotech (China), Zhejiang University · ORCID：0000-0003-2721-0377

发表论文 59 篇 · 总被引 414 次 · h-index 10

代表论文

Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice (2024 · Nature Communications · 被引 31)
Prognostic and predictive impact of molecular tumor burden index in non‐small cell lung cancer patients (2023 · Thoracic Cancer · 被引 10)
Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma (2023 · Aging · 被引 9)
Radiomic Analysis of Contrast-Enhanced MRI Predicts DNA Copy-Number Subtype and Outcome in Lower-Grade Gliomas (2021 · Academic Radiology · 被引 9)
Integration of longitudinal load-bearing tissue MRI radiomics and neural network to predict knee osteoarthritis incidence (2025 · Journal of Orthopaedic Translation · 被引 7)
Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas (2022 · Quantitative Imaging in Medicine and Surgery · 被引 7)